Fig. 5

Changes in lipid, kidney and liver profiles at 48 weeks. RPV rilpivirine, EFV efavirenz, PI protease inhibitor, LDL low density lipoprotein, HDL high density lipoprotein, ALT alanine aminotransferase
Changes in lipid, kidney and liver profiles at 48 weeks. RPV rilpivirine, EFV efavirenz, PI protease inhibitor, LDL low density lipoprotein, HDL high density lipoprotein, ALT alanine aminotransferase